|
Real-time
CBOE
18:30:00 19/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 3.724 EUR | 0.00% |
|
0.00% | -30.97% |
| 08-13 | Energiekontor hits March low, doubts over a strong second half | DP |
| 08-13 | Evotec's final first-half results once again spook investors | DP |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Discovery and Preclinical Development | - | - | - | 612M | 529M | |||||
Gross Profit | - | - | - | 102M | 46.81M | |||||
EBITDA | - | - | - | 12.7M | -12.04M | |||||
D&A | - | - | - | 77.24M | 74.77M | |||||
Operating Income | - | - | - | -126M | -74.48M | |||||
Just - Evotec Biologics | - | - | - | 187M | 260M | |||||
Gross Profit | - | - | - | 13.55M | 67.43M | |||||
EBITDA | - | - | - | 9.87M | 53.18M | |||||
D&A | - | - | - | 24.4M | 24.71M | |||||
Operating Income | - | - | - | -16.35M | 18.26M | |||||
EVT Innovate | 147M | 205M | 267M | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
EBITDA | -17.52M | -6.6M | 958K | - | - | |||||
D&A | 3.99M | 5.09M | 5.45M | - | - | |||||
Operating Income | -22.11M | -11.67M | -4.49M | - | - | |||||
EVT Execute | 610M | 736M | 739M | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
EBITDA | 125M | 108M | 65.39M | - | - | |||||
D&A | 63.62M | 76.57M | 87.53M | - | - | |||||
Operating Income | 63.11M | 32.52M | -43.02M | - | - | |||||
Transition | - | - | - | - | - | |||||
Intersegment Elimination | -139M | -189M | -224M | -1.21M | -496K | |||||
Gross Profit | - | - | - | -865K | -17K | |||||
Operating Income | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
USA | - | - | 459M | 446M | 432M | |||||
Total Assets | - | - | 221M | 258M | 216M | |||||
Switzerland | - | - | 64.92M | 109M | 162M | |||||
Total Assets | - | - | - | - | - | |||||
Total Assets | - | - | 2.63M | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Rest of the World | - | - | 95.15M | 82.28M | 77.08M | |||||
United Kingdom | - | - | 86.37M | 92.52M | 61.72M | |||||
Total Assets | - | - | 221M | 209M | 181M | |||||
Germany | - | - | 34.13M | 32.9M | 25.29M | |||||
Total Assets | - | - | 153M | 155M | 188M | |||||
France | - | - | 32M | 19.91M | 19.86M | |||||
Total Assets | - | - | 338M | 326M | 89.7M | |||||
Total Assets | - | - | 260M | 240M | 230M | |||||
Unallocated | - | - | - | 14.45M | 11.29M | |||||
Europe | - | - | - | - | - |
- Stock Market
- Stocks
- EVT Stock
- 0IRF Stock
- Financials Evotec SE
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
